000 | 01068 a2200289 4500 | ||
---|---|---|---|
005 | 20250514113027.0 | ||
264 | 0 | _c20000701 | |
008 | 200007s 0 0 eng d | ||
022 | _a0002-9955 | ||
024 | 7 |
_a10.1001/jama.1959.03010010003001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHORSTMANN, D M | |
245 | 0 | 0 |
_aAttenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population. _h[electronic resource] |
260 |
_bJournal of the American Medical Association _cMay 1959 |
||
300 |
_a1-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aHealth Facilities |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPoliomyelitis _ximmunology |
650 | 0 | 4 | _aPoliovirus |
650 | 0 | 4 | _aPoliovirus Vaccines |
650 | 0 | 4 | _aVaccines, Attenuated |
700 | 1 | _aNIEDERMAN, J C | |
700 | 1 | _aPAUL, J R | |
773 | 0 |
_tJournal of the American Medical Association _gvol. 170 _gno. 1 _gp. 1-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.1959.03010010003001 _zAvailable from publisher's website |
999 |
_c13407933 _d13407933 |